Christoph Högenauer

10PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMicrobial geneticsMedical devicesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 19, 2026
Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study.

|Apr 29, 2025
Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation.

Himadri B Thapa, Christina A Passegger, Dominik Fleischhacker

|Aug 31, 2024
Targeted isolation of Methanobrevibacter strains from fecal samples expands the cultivated human archaeome.

Stefanie Duller, Simone Vrbancic, Łukasz Szydłowski

|Mar 17, 2023
Complete Genome Sequence of Klebsiella oxytoca Strain AHC-6, Isolated from a Patient during Acute Antibiotic-Associated Hemorrhagic Colitis.

Johanna Dabernig-Heinz, Gabriel E Wagner, Eva Leitner

|Jun 22, 2022
Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective study.

Andreas Blesl, Wolfgang Petritsch, Lukas Binder

|Jun 21, 2021
Limited long-term treatment persistence of first anti-TNF therapy in 538 patients with inflammatory bowel diseases: a 20-year real-world study.

Andreas Blesl, Lukas Binder, Christoph Högenauer

Pageof 2

Frequent Collaborators

3 joint publications

Andreas Blesl

2 joint publications

Gregor Gorkiewicz

2 joint publications

Ellen L Zechner

1 joint publications

Magdalena Grill